Nationwide AMD Genetics Study Recruiting Participants
|
Dr. Michael Gorin at Jules Stein Eye Institute at UCLA is conducting a nationwide study of genetic and other risk factors that contribute to the development of age-related macular degeneration (also known as age-related maculopathy). You or members of your family may be eligible to participate in this observational study, (this is not a treatment trial) which does not require that you come to UCLA, but allows you to participate through a confidential and secure website. Visit https://jseiclinres.jsei.ucla.edu/garm/ or contact: 1-800-286-8581.
|
- Researchers Recommend Update to AREDS Formula for Reducing Advanced AMD Risk
- ACT Expands Human Studies of Stem-Cell Derived Retinal Treatment
- Retinal Symposium Focuses on Research and Financial Partnerships for Advancing Therapies
- Bone Marrow Stem Cells in Clinical Trial for Retinal Diseases
- Stem Cell Pioneers Creating Retinal Patch to Restore Vision














![Casting A Wide Net[work] | Presenting the interactive Foundation Fighting Blindness 2012 Annual Report 2012 Annual Report banner](https://www.blindness.org/images/banners/annual_report_box.jpg)


